Advanced Biomedical Technologies Inc. (ABMT) Financial Statements (2024 and earlier)

Company Profile

Business Address 200 PARK AVENUE, SUITE 1700
NEW YORK, NY 10166
State of Incorp.
Fiscal Year End October 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

7/31/2021
MRQ
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 202677738
Cash and cash equivalents 202677738
Inventory, net of allowances, customer advances and progress billings 10064   3
Inventory 10064   3
Prepaid expense    172018
Other undisclosed current assets 295033   
Total current assets: 33111940252759
Noncurrent Assets
Operating lease, right-of-use asset 33 
Property, plant and equipment 105991036172107
Other undisclosed noncurrent assets     1 
Total noncurrent assets: 138991036174107
TOTAL ASSETS: 46921914285101166
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Other liabilities   44340933897
Due to related parties 4,7064,9174,3263,7673,0843,528
Other undisclosed current liabilities 3,1581,7809939041,0421,002
Total current liabilities: 7,8646,6975,7615,0804,4634,627
Noncurrent Liabilities
Long-term debt and lease obligation: 7     
Operating lease, liability 7 
Total noncurrent liabilities: 14     
Total liabilities: 7,8786,6975,7615,0804,4634,627
Commitments and contingencies     1 
Equity
Equity, attributable to parent, including: (7,402)(6,478)(5,619)(4,995)(4,362)(4,461)
Common stock 111111
Additional paid in capital 2,8242,7682,7402,6742,5211,949
Accumulated other comprehensive income (loss) 2133427310104(148)
Accumulated deficit (10,256)(9,581)(8,633)(7,679)(6,988)(6,263)
Other undisclosed equity, attributable to parent 8     
Total equity: (7,402)(6,478)(5,619)(4,995)(4,362)(4,461)
Other undisclosed liabilities and equity (7)   (1) 
TOTAL LIABILITIES AND EQUITY: 46921914285101166

Income Statement (P&L) ($ in thousands)

7/31/2021
TTM
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
Revenues 12412    
Revenue from related parties 111  
Cost of revenue (52)(8)    
Gross profit: 724    
Operating expenses (518)(609)(634)(404)(461)(605)
Other operating expense, net      (258)
Other undisclosed operating income      258
Operating loss: (447)(605)(634)(404)(461)(605)
Nonoperating expense (225)(344)(19)(30)(14)(16)
Other nonoperating expense (22)(18)(19)(30)(14)(16)
Interest and debt expense (14)(13)(14)(16)(249)(241)
Loss from continuing operations before equity method investments, income taxes: (686)(962)(667)(449)(725)(863)
Other undisclosed income (loss) from continuing operations before income taxes 1413(287)(242)  
Loss from continuing operations: (672)(949)(953)(692)(725)(863)
Loss before gain (loss) on sale of properties:(672)(949)(953)(692)(725)(863)
Net loss available to common stockholders, diluted: (672)(949)(953)(692)(725)(863)

Comprehensive Income ($ in thousands)

7/31/2021
TTM
10/31/2020
10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
Net loss: (672)(949)(953)(692)(725)(863)
Other comprehensive income (loss) (313)62263(94)252119
Comprehensive loss, net of tax, attributable to parent: (985)(887)(691)(786)(472)(744)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: